These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 8605204

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as a substrate of cytochrome P450 2D6: allosteric effects of NADPH-cytochrome P450 reductase.
    Modi S, Gilham DE, Sutcliffe MJ, Lian LY, Primrose WU, Wolf CR, Roberts GC.
    Biochemistry; 1997 Apr 15; 36(15):4461-70. PubMed ID: 9109653
    [Abstract] [Full Text] [Related]

  • 4. Impact of incorporating the 2C5 crystal structure into comparative models of cytochrome P450 2D6.
    Kirton SB, Kemp CA, Tomkinson NP, St-Gallay S, Sutcliffe MJ.
    Proteins; 2002 Nov 01; 49(2):216-31. PubMed ID: 12211002
    [Abstract] [Full Text] [Related]

  • 5. The substrate binding site of human liver cytochrome P450 2C9: an NMR study.
    Poli-Scaife S, Attias R, Dansette PM, Mansuy D.
    Biochemistry; 1997 Oct 21; 36(42):12672-82. PubMed ID: 9335524
    [Abstract] [Full Text] [Related]

  • 6. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC, Roitel O, Marshall KR, Noble MA, Chapman SK, Pessegueiro A, Fulco AJ, Cheesman MR, von Wachenfeldt C, Munro AW.
    Biochemistry; 2004 May 11; 43(18):5474-87. PubMed ID: 15122913
    [Abstract] [Full Text] [Related]

  • 7. A refined substrate model for human cytochrome P450 2D6.
    de Groot MJ, Bijloo GJ, Martens BJ, van Acker FA, Vermeulen NP.
    Chem Res Toxicol; 1997 Jan 11; 10(1):41-8. PubMed ID: 9074801
    [Abstract] [Full Text] [Related]

  • 8. Baculovirus expression of human P450 2E1 and cytochrome b5: spectral and catalytic properties and effect of b5 on the stoichiometry of P450 2E1-catalyzed reactions.
    Patten CJ, Koch P.
    Arch Biochem Biophys; 1995 Mar 10; 317(2):504-13. PubMed ID: 7893169
    [Abstract] [Full Text] [Related]

  • 9. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC, Westlake AC, Maréchal JD, Joyce MG, Moody PC, Roberts GC.
    J Mol Biol; 2007 Oct 26; 373(3):633-51. PubMed ID: 17868686
    [Abstract] [Full Text] [Related]

  • 10. Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform.
    Zeldin DC, DuBois RN, Falck JR, Capdevila JH.
    Arch Biochem Biophys; 1995 Sep 10; 322(1):76-86. PubMed ID: 7574697
    [Abstract] [Full Text] [Related]

  • 11. Expression, purification, biochemical characterization, and comparative function of human cytochrome P450 2D6.1, 2D6.2, 2D6.10, and 2D6.17 allelic isoforms.
    Yu A, Kneller BM, Rettie AE, Haining RL.
    J Pharmacol Exp Ther; 2002 Dec 10; 303(3):1291-300. PubMed ID: 12438554
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases.
    Hoch U, Zhang Z, Kroetz DL, Ortiz de Montellano PR.
    Arch Biochem Biophys; 2000 Jan 01; 373(1):63-71. PubMed ID: 10620324
    [Abstract] [Full Text] [Related]

  • 14. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O, Scrutton NS, Munro AW.
    Biochemistry; 2003 Sep 16; 42(36):10809-21. PubMed ID: 12962506
    [Abstract] [Full Text] [Related]

  • 15. Purification and characterization of benzoate-para-hydroxylase, a cytochrome P450 (CYP53A1), from Aspergillus niger.
    Faber BW, van Gorcom RF, Duine JA.
    Arch Biochem Biophys; 2001 Oct 15; 394(2):245-54. PubMed ID: 11594739
    [Abstract] [Full Text] [Related]

  • 16. A preliminary 3D model for cytochrome P450 2D6 constructed by homology model building.
    Koymans LM, Vermeulen NP, Baarslag A, Donné-Op den Kelder GM.
    J Comput Aided Mol Des; 1993 Jun 15; 7(3):281-9. PubMed ID: 8377025
    [Abstract] [Full Text] [Related]

  • 17. A natural variant of the heme-binding signature (R441C) resulting in complete loss of function of CYP2D6.
    Klein K, Tatzel S, Raimundo S, Saussele T, Hustert E, Pleiss J, Eichelbaum M, Zanger UM.
    Drug Metab Dispos; 2007 Aug 15; 35(8):1247-50. PubMed ID: 17460029
    [Abstract] [Full Text] [Related]

  • 18. Truncated human P450 2D6: expression in Escherichia coli, Ni(2+)-chelate affinity purification, and characterization of solubility and aggregation.
    Kempf AC, Zanger UM, Meyer UA.
    Arch Biochem Biophys; 1995 Aug 20; 321(2):277-88. PubMed ID: 7646052
    [Abstract] [Full Text] [Related]

  • 19. Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF.
    Cupp-Vickery JR, Garcia C, Hofacre A, McGee-Estrada K.
    J Mol Biol; 2001 Aug 03; 311(1):101-10. PubMed ID: 11469860
    [Abstract] [Full Text] [Related]

  • 20. New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme.
    Wang B, Yang LP, Zhang XZ, Huang SQ, Bartlam M, Zhou SF.
    Drug Metab Rev; 2009 Aug 03; 41(4):573-643. PubMed ID: 19645588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.